Gaze Modification Strategies for Toddlers With Autism Spectrum Disorder
NCT ID: NCT02488226
Last Updated: 2020-03-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
81 participants
INTERVENTIONAL
2015-06-30
2016-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Development of Eye-tracking Based Markers for Autism in Young Children
NCT03286621
Tracking Intervention Effects With Eye Tracking
NCT02856061
Evaluating the Validity of an Eye Gaze Paradigm in Predicting Autism Spectrum Disorder
NCT02573428
Social Value Training in Toddlers With Elevated Autism Symptoms
NCT03556826
Using Serious Game Technology to Improve Sensitivity to Eye Gaze in Autism
NCT02968225
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Manual coding of live-action interaction probes will provide an additional evaluative measure, allowing the investigators to track real-world (live-action) correlates alongside video-eye-tracking behaviors. In addition, live-action probes may allow the investigators to check for generalization to live interaction with another person (as opposed to gaze behavior when watching videos). In live-action probes, one or two clinical research staff member(s) will interact with each participant (or with each other in front of the participant), in a manner analogous to the actions performed in the training videos.
Please note: The original estimated enrollment as specified to and funded by NIH was 98 participants, but was incorrectly listed on ClinicalTrials.gov as 220 participants reflecting maximal recruitment in this and other ongoing studies.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Gaze Contingent
Participants will view social videos using Gaze-contingent eye-tracking technology . If the participants looking patterns deviate from a normative pattern, they will be redirected to the normative point of regard using gaze-contingent cues.
Gaze-contingent eye-tracking technology
When participants look away from a prototypical or expected norm, their gaze patterns are redirected to those prototypical locations.
Control Condition
Participants will view unaltered social videos which do not change based on where the participant is looking.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Gaze-contingent eye-tracking technology
When participants look away from a prototypical or expected norm, their gaze patterns are redirected to those prototypical locations.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Fulfill criteria for autistic disorder or PDD-NOS (Pervasive Developmental Disorder- Not Otherwise Specified) on the Autism Diagnostic Observation Schedule - Module 1
* A diagnosis of autism or PDD-NOS by experienced clinicians
Exclusion Criteria
* Suspected or diagnosed hearing loss or visual impairment
* History of head trauma with loss of consciousness
* Non-febrile seizure disorders
* Diagnosed neurological abnormality significantly impacting on visual or auditory acuity.
18 Months
60 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yale University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Frederick Shic
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Frederick Shic, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Yale University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yale Child Study Center
New Haven, Connecticut, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1306012246
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.